Bold statement: Mental health disorders may share more of a common biological foundation than we once thought, challenging how we categorize and treat them. And this is the part most people miss: the overlaps aren’t cosmetic—they could redefine diagnosis and therapy in meaningful ways.
Major genetic research from the University of Colorado Boulder and Mass General Brigham analyzed DNA from over six million individuals, including more than a million with at least one mental health condition. This scale matters: the World Health Organization estimates billions live with mental health issues, highlighting the potential global impact if findings translate into practice.
Currently, psychiatric diagnoses rely heavily on observed symptoms rather than underlying biology. Many patients end up with multiple diagnoses, which can complicate treatment and dampen hope. The new study suggests there are five broad genetic patterns that explain most differences between people with and without these conditions, rooted in 238 genetic variants that influence brain development and function. Grouping disorders by these shared patterns yielded five categories:
- Compulsive-trait disorders: anorexia nervosa, Tourette syndrome, and obsessive-compulsive disorder.
- Internalising conditions: depression, anxiety, and post-traumatic stress disorder.
- Substance use disorders.
- Neurodevelopmental conditions: autism and attention-deficit/hyperactivity disorder.
- A bipolar/shizophrenia cluster.
A striking finding is that roughly 70% of the genetic signal associated with schizophrenia also relates to bipolar disorder, suggesting these two have more in common genetically than their divergent clinical histories imply.
What this means for patients and clinicians
The Nature paper challenges the view that mental illnesses are largely separate diseases. Instead, many conditions may arise from shared biological mechanisms. Yet, researchers caution that it is premature to alter diagnostic practices immediately. Still, the work could guide future revisions of the Diagnostic and Statistical Manual of Mental Disorders (DSM) and inform more integrated treatment approaches.
As Grotzinger, the study’s lead author, notes, identifying shared biology across disorders could enable strategies that do not require four different pills or four separate therapy plans. In other words, understanding common pathways might allow for more streamlined, targeted interventions.
The study also maps biology to specific brain processes. For instance, genes linked to excitatory neurons—crucial for brain signaling—were more active in people with bipolar disorder and schizophrenia. By contrast, genetic variants associated with oligodendrocytes, cells that support neural connections, were more common in depression and anxiety. These insights point to distinct biological routes within broader shared patterns.
Some genetic influences appear to shape brain development very early, possibly before birth, while others become more influential later in life. This mix could help explain why mental health conditions often overlap and why people with one disorder frequently receive additional diagnoses over time.
Contextual note
A 2018 review highlighted how common it is for individuals with one psychiatric diagnosis to receive subsequent diagnoses. More than half later have another, and about 41% meet criteria for four or more across their lifetimes. The current findings don’t erase this reality but offer a framework to understand why overlap occurs.
In short, the study points to a more unified biological picture of mental health, with implications for diagnosis, treatment, and future research. It invites thoughtful discussion: Do these shared pathways justify a move toward more holistic, mechanism-based care, or might they blur the lines between distinct disorders in ways that complicate personalized treatment? Share your perspective in the comments.
